[The value of gynosterosan in vulvovaginal moniliasis].
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000628:therapy*; D002181:Candidiasis, Vulvovaginal; D004194:Disease; D005260:Female; D005659:Fungicides, Industrial; D006219:Halogens; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use*; D014621:Vagina; D014623:Vaginal Diseases; D014844:Vulva; D014845:Vulvar Diseases
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D005659:Fungicides, Industrial; D006219:Halogens; D006846:Hydrocarbons, Halogenated
ANTISEPTICS, HALOGEN/therapeutic use; FUNGICIDES/therapeutic use; MONILIASIS/therapy; VAGINA/diseases; VULVA/diseases
Was leistet Gyno-Sterosan bei vulvo-vaginalem Soor.